PLA2 and HMG-COA inhibitors for the treatment of conditions causing hemolysis, brain edema and acute kidney injury

摘要

A condition that causes hemolysis, cerebral edema, acute kidney injury and non-anaphylactic shock, including poison injection, trauma, cerebral malaria and mastocytosis, using at least one PLA2 inhibitor alone or in combination with other agents Therapeutic methods are provided. The unexpected versatility of PLA2 inhibitors, their dosage forms and combinations makes them an essential pharmaceutical candidate in developing countries.